Imatinib-induced extensive hyperpigmentation in a case of chronic myeloid leukemia

• मुख्य लेखकों: Pradeep Balasubramanian (लेखक), Soumya Jagadeesan (लेखक), Jacob Thomas (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Wolters Kluwer Medknow Publications, 2015-01-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Imatinib, a tyrosine kinase inhibitor, is well known to cause hypopigmentation because of its inhibitory effect on melanocytes. Herewith we report a case of chronic myeloid leukemia who developed extensive hyperpigmentation following imatinib therapy.